Clinical Trials
Braintumor Website

There are 25 trials:
Facility: Henry Ford Hospital
NCT Trial Name# of Centers

NCT02834013

  Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
224

NCT00991029

  Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
210

NCT01622868

  Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
131

NCT02614794

  Study of ONT-380 vs Placebo in Combo w/ Capecitabine & Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
111

NCT02360215

  Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
100

NCT01977651

  A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
93

NCT02635009

  Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
91

NCT00045968

  Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
70

NCT02796261

  Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
69

NCT00377156

  Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
65

NCT01960075

  Established Status Epilepticus Treatment Trial
49

NCT02526017

  Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
39

NCT02844439

  Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma
10

NCT02658981

  Anti-LAG-3 or Urelumab Alone and in Combination With Nivolumab in Treating Patients With Recurrent Glioblastoma
10

NCT01156584

  A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
10

NCT01790503

  A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
9

NCT02632370

  5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
9

NCT02133183

  Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
7

NCT02395692

  Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
7

NCT01480050

  Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
7

NCT01470794

  Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
6

NCT02101905

  Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
5

NCT02375841

  Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
5

NCT01112527

  PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
4

NCT01985256

  Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
4



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites